S. 5059 · 119th Congress

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

Stage
In committee
Introduced
2026-07-21
Latest action
2026-07-21 · Introduced in Senate

Votes

No linked votes are available for this bill.